| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.17▼ | 3.19▼ | 3.19▼ | 3.13▲ | 3.17▲ |
| MA10 | 3.19▼ | 3.17▼ | 3.17▼ | 3.18▼ | 3.91▼ |
| MA20 | 3.19▼ | 3.22▼ | 3.22▼ | 3.20▼ | 3.94▼ |
| MA50 | 3.22▼ | 3.23▼ | 3.23▼ | 4.08▼ | 2.99▲ |
| MA100 | 3.23▼ | 3.30▼ | 3.60▼ | 3.88▼ | 2.91▲ |
| MA200 | 3.63▼ | 4.15▼ | 4.27▼ | 3.10▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.005▼ | -0.004▼ | 0.048▲ | -0.218▼ |
| RSI | 45.584▼ | 45.509▼ | 45.307▼ | 38.913▼ | 44.616▼ |
| STOCH | 54.274 | 58.945 | 58.945 | 33.042 | 15.704▼ |
| WILL %R | -38.462 | -62.791 | -62.791 | -60.976 | -81.466▼ |
| CCI | -1.550 | -40.638 | -40.638 | -20.023 | -87.378 |
|
Thursday, May 14, 2026 02:22 PM
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
|
|
Wednesday, February 11, 2026 04:00 PM
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.
|
|
Wednesday, January 28, 2026 03:23 AM
Penumbra, Inc. (NYSE: PEN) related to its sale to Boston Scientific Corporation. Under the terms of the proposed transaction, Penumbra shareholders are expected to receive 3.8721 shares of Boston ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/05/26 | 3.20 | 3.23 | 3.16 | 3.18 | 16,279 |
| 19/05/26 | 3.12 | 3.175 | 3.12 | 3.12 | 2,454 |
| 18/05/26 | 3.155 | 3.155 | 3.12 | 3.12 | 3,694 |
| 15/05/26 | 3.02 | 3.22 | 3.02 | 3.17 | 23,224 |
| 14/05/26 | 3.28 | 3.28 | 3.08 | 3.08 | 42,211 |
| 13/05/26 | 3.21 | 3.37 | 3.21 | 3.28 | 29,068 |
| 12/05/26 | 3.20 | 3.3845 | 3.20 | 3.26 | 18,016 |
| 11/05/26 | 3.09 | 3.28 | 3.09 | 3.26 | 60,043 |
| 08/05/26 | 3.20 | 3.21 | 3.15 | 3.15 | 19,847 |
| 07/05/26 | 3.255 | 3.346 | 3.13 | 3.23 | 52,694 |
|
|
||||
|
|
||||
|
|